Patents by Inventor Lyle F. Ralston

Lyle F. Ralston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10184119
    Abstract: The invention relates to isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention relates to uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: January 22, 2019
    Assignee: The University of Kentucky Research Foundation
    Inventors: Joseph Chappell, Lyle F. Ralston
  • Patent number: 10184118
    Abstract: The invention relates to isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention relates to uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: January 22, 2019
    Assignee: The University of Kentucky Research Foundation
    Inventors: Joseph Chappell, Lyle F. Ralston
  • Publication number: 20160032256
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Application
    Filed: August 24, 2015
    Publication date: February 4, 2016
    Applicant: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: Joseph Chappell, Lyle F. Ralston
  • Publication number: 20160024530
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Application
    Filed: August 24, 2015
    Publication date: January 28, 2016
    Applicant: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: Joseph Chappell, Lyle F. Ralston
  • Publication number: 20140212939
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Application
    Filed: April 2, 2014
    Publication date: July 31, 2014
    Inventors: JOSEPH CHAPPELL, LYLE F. RALSTON
  • Patent number: 8722363
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: May 13, 2014
    Assignee: University of Kentucky Research Foundation
    Inventor: Lyle F. Ralston
  • Publication number: 20130330793
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Application
    Filed: May 3, 2013
    Publication date: December 12, 2013
    Inventors: Joseph Chappell, Lyle F. Ralston
  • Patent number: 8445231
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: May 21, 2013
    Assignee: University of Kentucky Research Foundation
    Inventors: Joseph Chappell, Lyle F. Ralston
  • Patent number: 8263362
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Grant
    Filed: July 29, 2008
    Date of Patent: September 11, 2012
    Assignee: University of Kentucky Research Foundation
    Inventors: Joseph Chappell, Lyle F. Ralston
  • Publication number: 20110318797
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Application
    Filed: August 26, 2011
    Publication date: December 29, 2011
    Inventors: Joseph Chappell, Lyle F. Ralston
  • Patent number: 7405057
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Grant
    Filed: March 8, 2002
    Date of Patent: July 29, 2008
    Assignee: Board of Trustees of the University of Kentucky
    Inventors: Joseph Chappell, Lyle F. Ralston
  • Publication number: 20030166255
    Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
    Type: Application
    Filed: March 8, 2002
    Publication date: September 4, 2003
    Inventors: Joseph Chappell, Lyle F. Ralston